From: Clinical drug trials in general practice: a 10-year overview of protocols
Does this apply for the ONE trial? | |
---|---|
Tests a new drug recently or about to be licensed | Yes: application year 2000, study completed by the end of 2001; esomeprazole licensed in 2001 |
Many well established competing products | Yes: omeprazole from 1989, lansoprazole and pantoprazole from 1995 |
Many patients included | Yes: 2,500 patients (the trial with most Norwegian patients to be included). In addition, similar studies have been conducted in other countries (see main text). |
Frequent prescribers in the role of clinical investigators | Yes: 402 general practitioners (GPs; the study involving most Norwegian GP investigators) |
Often redundant as they are not designed for answering a scientific problem | Probably yes |
Unreasonably high payments for the investigators | No: €750 which is below the 25th percentile for all trials |
Results are often not published | No: there were three publications |
Conducted by drug company marketing departments | Unknown |